Klivira
Request demo

Cardiac Ablation Prior Authorization for Dermatology: A Unified PA Approach

Navigating Cardiac Ablation prior authorization for dermatology patients requires a robust system capable of managing diverse clinical needs. Klivira streamlines these complex workflows across all specialties within your health system.

While direct clinical overlap between cardiac ablation and dermatology is uncommon, health systems frequently manage patients with conditions spanning both specialties. This presents a unique challenge in prior authorization, demanding a platform that can efficiently process high-cost cardiac procedures alongside chronic dermatological treatments.

Navigating Diverse Prior Authorization Needs for Complex Patients

Patients often present with comorbidities requiring care across multiple specialties. For instance, a patient receiving biologics for severe psoriasis from dermatology may also require cardiac ablation for an arrhythmia. Managing prior authorizations for such diverse, high-cost, and medically necessary procedures demands an integrated and efficient approach across the revenue cycle.

Cardiac Ablation: A High-Acuity Prior Authorization Process

Cardiac ablation, typically performed for conditions like atrial fibrillation, is a high-cost procedure subject to rigorous medical necessity review by payers. Authorization requests require comprehensive documentation, including diagnostic test results, conservative treatment trials, and cardiology consultation notes, to justify the intervention. While not a dermatology procedure, the administrative burden of its PA process impacts overall health system efficiency.

Dermatology Prior Authorization: High Volume and Specific Criteria

Dermatology prior authorization is characterized by high volume, particularly for biologics used in conditions like psoriasis, atopic dermatitis, and hidradenitis suppurativa, as well as for Mohs micrographic surgery. Payers often require specific documentation, including PASI/BSA scores, EASI/SCORAD severity, prior topical and systemic therapy trials, and adherence to AAD Clinical Guidelines or Mohs Appropriate Use Criteria for approval.

Addressing Common Prior Authorization Denials in Dermatology

Denials in dermatology frequently stem from non-compliance with step therapy protocols, such as insufficient documentation of prior topical or conventional systemic therapy trials for biologics. Other common reasons include inadequate disease severity scoring (e.g., missing PASI/BSA), biosimilar substitution requirements, or Mohs surgery not meeting payer-specific AUC indications. Proactive validation against payer policies is critical.

Klivira: Unifying Prior Authorization Across Diverse Specialties

Klivira's platform is designed to manage the full spectrum of prior authorization requirements, from high-acuity cardiac procedures like ablation to the high-volume, guideline-driven demands of dermatology. By integrating with EMRs and payer portals, our system applies specific logic for each specialty, including AAD-guideline-aware step-therapy for biologics and AUC validation for Mohs surgery, alongside complex medical necessity reviews for cardiology. This ensures consistent, accurate, and timely submissions across your entire organization.

Frequently asked questions

How does Klivira handle the different documentation requirements for cardiology and dermatology PAs?

Klivira's platform employs configurable rules engines that apply specialty-specific logic. For cardiology, it validates diagnostic reports and conservative treatment trials for procedures like cardiac ablation. For dermatology, it ensures compliance with AAD Clinical Guidelines, including step therapy for biologics and AUC for Mohs surgery, streamlining documentation retrieval and submission.

Can Klivira manage re-authorizations for chronic dermatology biologics and one-time cardiac procedures?

Yes, Klivira is built to manage both periodic re-authorizations for chronic treatments, common in dermatology for biologics (e.g., 6/12-month cycles), and one-time authorizations for procedures such as cardiac ablation. The system tracks authorization expiry, triggers renewal workflows, and adapts to the specific re-authorization requirements of each payer and procedure.

What role does EMR integration play in managing PAs for these disparate specialties?

EMR integration is central to Klivira's efficiency. It allows for automated extraction of necessary clinical data—such as diagnosis codes, treatment history, and lab results—directly from the EMR for both cardiac and dermatological prior authorizations. This reduces manual data entry, minimizes errors, and accelerates the submission process for diverse PA types.

How does Klivira help prevent denials for both complex cardiac ablations and high-volume dermatology treatments?

Klivira prevents denials by proactively validating authorization requests against payer-specific rules and clinical guidelines before submission. This includes checking for complete documentation, adherence to step therapy protocols for biologics, and appropriate use criteria for Mohs surgery or cardiac ablation, significantly reducing the likelihood of common denial reasons.

Is Klivira compatible with both medical and pharmacy benefit PAs relevant to dermatology?

Yes, Klivira supports both medical and pharmacy benefit prior authorizations. This is crucial for dermatology, where biologics can route through either benefit depending on the site of administration (self-injection at home vs. clinic infusion). Our platform routes requests appropriately and manages the distinct workflows for each benefit type.

Related coverage

Other cardiac-ablation prior authorization by payer

Other cardiac-ablation prior authorization by specialty

Ready to automate prior auth for this procedure?

See how Klivira automates prior authorizations for your team.

Request a demo